What is PMCB's dilution risk score?

PMCB has a latest available DilutionScore record of 37/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for PMCB, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for PMCB?

DilutionWatch tracks 25 SEC filing types for PMCB including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect PMCB shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For PMCB, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for PMCB tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for PMCB. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

PMCB Dilution Risk Score: 37/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

42

💰 Cash Runway

0

📊 Float Risk

30

⚠️ Warrant Exposure

90

🔄 Convertible Debt

40

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 46%

📜 Warrant Exercise model 60%

• Massive warrant overhang: 317% of shares outstanding

• Warrant risk score very high (90/100)

🔄 Reverse Split model est. 55%

• 50-day avg $0.75 below $1 exchange minimum

🔔 Track PMCB — Get forecast alerts →

Market Data

Market Cap$8.96M

Shares Outstanding10.74M

Float9.96M

Cash$18.86M

Debt$2.46M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 0.7% shares (2026Q1 vs prior)

32 institutional holders · 1.18M shares

#1 CITADEL ADVISORS LLC 519.7K shares

#2 GEODE CAPITAL MANAGEMENT, LLC 195.7K shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 102.9K shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest292.0K

Days to Cover1.9

% of Float2.9%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-04-30

xbrl XBRL CONVERTIBLE 2024-04-30

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual PMCB Dilution Snapshot

PharmaCyte Biotech, Inc. (PMCB) has a DilutionScore of 37/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 34.0M.
Recent SEC activity tracked for PMCB: xbrl on 2026-04-30; xbrl on 2024-04-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.